Small molecule biotechnology company Iambic Therapeutics (IAM.US) sets IPO price at $15-17 per share, plans to raise $150 millions
智通财经2026/10/09 07:06According to Jinse Finance, it has been reported that Iambic Therapeutics (IAM.US), a biotechnology company developing small-molecule anti-cancer therapies based on its self-developed artificial intelligence (AI) platform and currently in Phase I clinical trials, announced its IPO terms on Thursday. The San Diego, California-based company plans to raise $150 million by offering 9.4 million shares at a price range of $15 to $17 per share. Some investors have already expressed their intention to purchase $60 million worth of shares in this offering, accounting for 40% of the deal. At the midpoint of the proposed price range, Iambic Therapeutics would have a fully diluted market value of $809 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The Central Bank of Malaysia allocates an additional 5 billions ringgit in financing to SMEs affected by the Middle East conflict.
The Prime Minister of Malaysia stated that the central bank will provide an additional 5 billion ringgit in financing to small and medium-sized enterprises affected by the Middle East conflict.
The yield on Italy's 10-year government bonds has fallen below 4.55%, retreating from a three-year high.
⑴ Italy's 10-year government bond yield fell below 4.55%, retreating from a three-year high as falling oil prices eased the bond sell-off triggered by concerns surrounding Europe's fiscal outlook. ⑵ US President Trump stated that the United States will not attack Iran before next month's midterm elections, easing market concerns about further disruptions to energy supplies. ⑶ Italy's risk premium narrowed, with the yield spread over safe-haven German government bonds dropping to 107 basis points from 130 basis points last Friday. ⑷ The market has also reduced bets on European Central Bank rate hikes, now expecting the policy rate to be 3.2% by the end of 2027. ⑸ However, yields remain near multi-year highs, and Italy's debt-to-GDP ratio of 138.6% is expected to exceed that of Greece this year, making it the most indebted country in the Eurozone. ⑹ The European Commission's fiscal chief urged budget restraint, rejecting calls from Italy and Greece for greater budgetary flexibility. ⑺ Meanwhile, the Italian government is in talks with banks and energy groups about possible contributions as it prepares to submit the 2027 budget next week.
Spot gold surpasses $4,200/oz, rising 1.61% on the day
Spot gold has just surpassed the $4,200.00/ounce mark, now trading at $4,200.18/ounce, up 1.61% for the day. The main COMEX gold futures contract is currently quoted at $4,224.80/ounce, up 1.63% for the day.
Honda plans to purchase Mitsubishi Motors OEM pickup trucks to strengthen cooperation with Nissan and Mitsubishi
According to Nikkei News, Honda has decided to procure complete vehicles from Mitsubishi Motors through an Original Equipment Manufacturer (OEM) arrangement. This will mark Honda's first vehicle procurement from another automaker in about 30 years. As market competition intensifies, Honda aims to strengthen its partnerships with Nissan and Mitsubishi Motors to enhance competitiveness. The three companies have made progress in joint discussions that began in August 2024. According to the plan, Mitsubishi Motors will produce the L200 Triton pickup truck in Thailand, branded with the Honda logo, and it will be sold in Southeast Asian and other markets starting from 2028 and beyond.
Crypto prices
More
